drugset / Trial / NCT00619112

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

NCT00619112 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with recurrent high-grade glioma.

Timeline

Start
2007-10
Primary completion
2011-12
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule 150 mg/m2 Oral